WINNINGHAM RICK E (Chief Executive Officer) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/9/2024ACC: 0001415889-24-021057
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+3.25K
Net shares
Net buyer
$25.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
3.25K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+3.25K
Price / share
$7.83
Trade value
$25.46K
% of position
0.2%
8/7/2024
1.84M→1.84M
Total
Net shares
+3.25K
Net value
$25.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 8/7/2024 | A · Award | +3.25K | $7.83 | $25.46K | 0.2% | 1.84M | 1.84M |
| Total | +3.25K | $25.46K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned3.90K
Ordinary Shares
IndirectShares owned92.57K
Total
96.47K indirect96.47K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 3.90K | Indirect |
| Ordinary Shares | 92.57K | Indirect |
| Total | 96.47K | 96.47K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported